Positive ezrin and paxillin protein expression was seen in 99% and 93.7%, respectively, of urothelial tumors; downregulation of ezrin and paxillin in urothelial bladder tumors was associated with aggressive tumor features and invasiveness [55]. This evidence concerns the gene EZR and neoplasm.